Core Insights - Synthetic biology company "YouTian Bio" recently secured several million yuan in angel round financing, led by Changzhou Qihang Synthetic Biology Venture Capital Fund, to focus on the large-scale production of somatostatin, expand its synthetic biology product pipeline, and iterate its technology platform [1] Company Overview - YouTian Bio was established in 2023 by founder and chairman Cui Junsheng, a serial entrepreneur with a background in biology from Nankai University, who has previously participated in significant national drug development projects [1] - The company aims to initiate a "sweetness revolution" from carbohydrates to proteins by leveraging new technologies in collaboration with professors from institutions like the Chinese Academy of Sciences and Tsinghua University [1] Product Development - YouTian Bio has overcome the challenges of developing and mass-producing the natural sweet protein "somatostatin" through synthetic biology technology, establishing a large-scale fermentation system in Changzhou [1][3] - Somatostatin is a natural high-intensity sweet protein with a sweetness level up to 3000 times that of sucrose, offering advantages such as no aftertaste and being digested into amino acids without causing blood sugar spikes [3] Market Potential - The demand for low-sugar, low-calorie health foods is increasing globally, driving the growth of the natural food additive market, particularly for protein sweeteners [6] - YouTian Bio's innovative approach aims to address the limitations of existing sweeteners, which include high costs and health risks associated with consumption [2][3] Technology Platform - The company has developed the Bio-Sup™ technology platform, which integrates research and development, pilot testing, and mass production, ensuring a complete technological chain [4][5] - This platform includes a rich library of chassis strains and functional components, enabling efficient design and integration of metabolic pathways to ensure high yield potential [5] Production Capacity - YouTian Bio's production base is located in the Changzhou Liyang High-tech Zone, where it is building a standardized and large-scale fermentation production system, having completed industrial trial production and is advancing a 30-ton fermentation scale production line [5][6] - The recent investment will further enhance production capacity and strengthen the research and development team, facilitating collaboration with upstream and downstream companies in the food and beverage industry [6]

Core Viewpoint - The article discusses the recent angel round financing of "YouTian Biotechnology," which aims to scale up the production of the natural sweet protein "Soma Sweet" using synthetic biology technology, addressing the challenges of high costs and limited supply in the natural sweetener market [1][9]. Company Overview - YouTian Biotechnology was established in 2023 by Chui Junsheng, a serial entrepreneur with a background in biology from Nankai University. The company focuses on synthetic biology and aims to revolutionize the sweetener industry by developing Soma Sweet through microbial fermentation [1][9]. Product Development - Soma Sweet, a natural high-intensity sweet protein discovered in the West African yam fruit, is 3000 times sweeter than sucrose and has no aftertaste, making it suitable for various food applications [5][6]. - The company has developed a Bio-Sup™ technology platform that integrates gene analysis, AI protein structure optimization, and process development, allowing for the creation of multiple product lines, including Soma Sweet and various enzymes [1][12]. Market Potential - The demand for low-sugar and low-calorie food products is increasing globally, and the market for natural protein sweeteners is expected to grow significantly. YouTian Biotechnology aims to meet this demand by expanding its product line and collaborating with food and beverage companies [13]. Production Capabilities - The production facility is located in the Changzhou Liyang High-tech Zone, where a standardized and scalable fermentation production system is being established. The company has completed industrial-scale pilot production and is working on a production line with a capacity of 30 tons [13]. - The use of synthetic biology for the production of Soma Sweet allows for stable supply and cost reduction, addressing the previous challenges of low availability and high prices associated with natural extraction methods [9][12]. Investment and Future Plans - The recent funding from Changzhou Qihang Synthetic Biology Venture Capital Fund will be used to enhance production capacity, strengthen the research team, and accelerate market penetration of Soma Sweet [13].